Back

A Small Interfering Peptide Potentiates AMPA Receptor Diffusional Trapping and Prevents Social-Isolation-Induced Forgetting of Fear Memory

Gundersen, J. E. T.; Wu, X.; Song, J.; Yao, J.; Nesbo, H. H.; Pokharna, A.; Mergiya, T. F.; Liu, H.; Sun, S.; Greger, I.; Wang, C.; Xu, N.-j.; Bramham, C. R.; Zhang, H.

2024-08-07 neuroscience
10.1101/2024.08.04.606518 bioRxiv
Show abstract

Regulation and dysregulation of AMPA receptor (AMPAR) diffusional trapping at synapses are critical for synaptic efficacy and are implicated in various neurological and neuropsychiatric disorders. However, the limited availability of reliable tools to modulate this process hinders our ability to explore its role in both physiological conditions and disease, as well as in drug development. In this study, we designed and characterized a 21-amino-acid trans-activator of transcription (TAT)-fused peptide that mimics the binding region of the transmembrane AMPAR regulatory proteins (TARPs) C-tail to the activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) N-lobe. Acute intrahippocampal infusion of this peptide enhanced perforant path-evoked synaptic transmission in the rat dentate gyrus (DG) in vivo, likely by strengthening the interaction between TARP and postsynaptic density protein 95 (PSD-95), a mechanism crucial for the synaptic anchoring of AMPARs. Additionally, the peptide also slowed AMPAR lateral diffusion and blocked KCl-induced AMPAR endocytosis, likely by enhancing the diffusional trapping of AMPARs at the synapse. Remarkably, a 7-day peptide infusion prevented social-isolation-induced forgetting of fear memory. Our findings suggest that targeting AMPAR diffusional trapping, particularly through disrupting the TARP-Arc N-lobe interaction, could hold promise as a therapeutic approach for neurological and neuropsychiatric disorders associated with impaired AMPAR synaptic retention.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
ACS Chemical Neuroscience
67 papers in training set
Top 0.1%
19.1%
2
eLife
5828 papers in training set
Top 9%
10.0%
3
Scientific Reports
3612 papers in training set
Top 6%
8.1%
4
Molecular Psychiatry
282 papers in training set
Top 0.9%
7.0%
5
Nature Communications
5641 papers in training set
Top 23%
7.0%
50% of probability mass above
6
Journal of Neurochemistry
53 papers in training set
Top 0.2%
3.3%
7
iScience
1154 papers in training set
Top 10%
2.5%
8
Communications Biology
993 papers in training set
Top 8%
2.5%
9
The Journal of Neuroscience
1025 papers in training set
Top 7%
1.8%
10
International Journal of Molecular Sciences
494 papers in training set
Top 7%
1.8%
11
Neuropsychopharmacology
153 papers in training set
Top 2%
1.5%
12
Frontiers in Pharmacology
111 papers in training set
Top 2%
1.4%
13
Frontiers in Molecular Neuroscience
47 papers in training set
Top 0.8%
1.2%
14
Molecular Neurobiology
53 papers in training set
Top 0.9%
1.2%
15
Translational Psychiatry
260 papers in training set
Top 3%
1.2%
16
Cell Reports
1498 papers in training set
Top 22%
1.2%
17
Advanced Science
286 papers in training set
Top 6%
1.2%
18
PLOS ONE
5266 papers in training set
Top 58%
1.0%
19
Progress in Neurobiology
47 papers in training set
Top 0.7%
1.0%
20
npj Parkinson's Disease
105 papers in training set
Top 1%
1.0%
21
Molecular Brain
28 papers in training set
Top 0.4%
0.9%
22
Brain
168 papers in training set
Top 3%
0.9%
23
Cell Death & Disease
126 papers in training set
Top 4%
0.6%
24
Neuroscience Letters
32 papers in training set
Top 0.7%
0.6%
25
Biomedicine & Pharmacotherapy
42 papers in training set
Top 2%
0.6%
26
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 43%
0.6%
27
British Journal of Pharmacology
40 papers in training set
Top 0.9%
0.6%
28
Brain Research
38 papers in training set
Top 0.9%
0.6%
29
Science Advances
1243 papers in training set
Top 35%
0.5%
30
Glia
81 papers in training set
Top 2%
0.5%